Publication | Closed Access

Reversion of β25–35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists

Synaptic PlasticityNeurodegenerative DiseasesMolecular NeuroscienceAlzheimer's Diseaseβ25–35-Amyloid Peptide-induced AmnesiaMedicineDementiaNeuropharmacologyNeurologyNeuroscienceMolecular NeurobiologyNeurochemistryPharmacologySynaptic SignalingSocial Sciences